Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 548
Selected: 0
NCT IDTitle
NCT06366997Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test
NCT05544149TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors
NCT06031597Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy
NCT04264468Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test
NCT07343479Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases
NCT06802835EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
NCT05589480Machine Learning for Recurrence Risk of Pancreatic Cancer After Radical Resection
NCT01405079Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation
NCT01928836Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China
NCT07252362LCMS-Based Metabolic Analysis Explores the Effect of American Ginseng on Urine and Plasma in Healthy Individuals
NCT04380012A Clinical Study of Pyrotinib in Patients With HER2-positive Advanced Colorectal Cancer
NCT01872962Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT06334783TIL for Patients With Advanced Solid Tumor
NCT05596071Whether Opioids Are Factor That Induced POD?
NCT07486700The Phase I Study of SIG001 Antibody on Cancer Therapy.
NCT06425757Study on Pharmacokinetics of Single Injection of Ciprofol in Patients With Moderate to Severe Hypoproteinemia
NCT06863831A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC
NCT06190639A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC
NCT01398449Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0
NCT03657017PET/MR in Locally Advanced Nasopharyngeal Carcinoma
NCT06289751Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
NCT07416890Thiotepa in Combination With Pirtobrutinib (a BTK Inhibitor) and Sintilimab (a PD-1 Inhibitor) for Frail or Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma
NCT04446091A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)
NCT07271823Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
NCT06214195The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
NCT03147963Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer
NCT05322499Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer
NCT03876587Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC
NCT06308939Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial
NCT03499782Precise Treatment System of Biliary Malignancies Based on Special Disease Database
NCT05131841Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC
NCT05557656A Real World Study of Regogfinib in HCC
NCT01815853Neoadjuvant Chemoradiotherapy vs. Chemotherapy Followed by Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer
NCT07074353Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NCT03204734Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer
NCT03759275pMDT in Thoracic Surgery--------For the Baseline Investigation and Technical Preparation Stage
NCT04049344Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma
NCT05075512The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer
NCT06374901Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.
NCT07253194Electroacupuncture on Postoperative Urinary Retention After Radical Surgery for Cervical Cancer
NCT04543890A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC
NCT03339882Remifemin Preventing the Climacteric Symptoms in Breast Cancer
NCT05512286Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction
NCT01836991D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer
NCT06146946Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
NCT05514275Radiotherapy Combined With Endostatin and Capecitabine for NPC
NCT05928312Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer
NCT05410444The Role of Clean Intermittent Catheterization in Patients Undergoing Radiotherapy After Radical Hysterectomy for Cervical Cancer
NCT01514877Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer
NCT04319471Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma